95 completed, 33 unknown, 9 withdrawn, 7 recruiting. 152 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 152 | Completed 95, Unknown 33, Withdrawn 9, Recruiting 7, Not yet recruiting 4, Enrolling by invitation 2, Active not recruiting 1, Terminated 1 |
Follow Esomeprazole: new trials by email Literature Review of Esomeprazole trials Research Report on Esomeprazole
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Esomeprazole Plus Sucralfate for Post-ESD Ulcer Healing Esomeprazole (Intravenous), Esomeprazole (Oral), Sucralfate Suspension - Early Gastric Cancer, Gastric Dysplasia | Phase 4 | Not yet recruiting | LanZhou University | 120 | 2026-04-20 | 2026-03-23 |
| Effects of Adjunctive N-Acetylcysteine and Curcumin on Helicobacter Pylori Eradication and Dyspeptic Symptoms: A Randomized Controlled Trial Esomeprazole + Amoxicillin + Levofloxacin + Bismuth, N-acetylcysteine (NAC) 600 mg, Curcumin (Turmeric) - HELICOBACTER PYLORI INFECTIONS | Phase 4 | Completed | University of Thi-Qar | 150 | 2026-01-20 | 2026-11-17 |
| Saccharomyces Boulardii Combined With Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Treatment Bismuth, Esomeprazole, Tetracycline - Gastritis, Dyspepsia | Phase 4 | Recruiting | Yongquan Shi | 1248 | 2025-10-28 | 2025-12-02 |
| Heartburn, Gastroesophageal Reflux Disease Zastaprazan, Esomeprazole - GERD | Phase 4 | Recruiting | Incheon St.Mary's Hospital | 160 | 2025-07-07 | 2025-12-23 |
| Vonoprazan Evaluation Compared to Standard Triple Therapy in Helicobacter Pylori eRadication Vonoprazan 20mg, Esomeprazole 40 mg, Amoxicillin 1 g, Clarithromycin 500 mg - Helicobacter Pylori Infection | Phase 4 | Recruiting | Asian Institute of Gastroenterology, India | 484 | 2025-03-25 | 2025-06-11 |
| Indonesian Study of Vonoprazan Vs Esomeprazole in Erosive Esophagitis Vonoprazan 20 mg, Esomeprazole - Erosive Esophagitis | Phase 4 | Not yet recruiting | Universitas Indonesia | 216 | 2024-12-09 | 2024-12-17 |
| Efficacy and Safety of Vonorasan Versus Esomeprazole in the Treatment of Ulcers After Endoscopic Submucosal Dissection Vonoprazan, Esomeprazole - Ulcers, Gastric | Phase 4 | Recruiting | Shicai Ye | 196 | 2024-12-02 | 2026-11-02 |
| Efficacy and Safety of Tegoprazan and Minocycline Dual Therapy for Helicobacter Pylori Initial Treatment tegoprazan, Minocycline, bismuth potassium citrate - Helicobacter Pylori Infection Chronic Gastrit | Phase 4 | Active not recruiting | Xijing Hospital of Digestive Diseases | 208 | 2024-11-11 | 2025-07-03 |
| Study on The Efficacy and Safety of Vonoprazan-containing Berberine Triple Therapy in Helicobacter Pylori First-Line Eradication Berberine, Vonoprazan, Amoxicillin - Helicobacter Pylori Infection, Chronic Gastritis | Phase 4 | Completed | Xijing Hospital of Digestive Diseases | 558 | 2024-09-20 | 2025-07-03 |
| Optimal Duration of Bismuth Quadruple Therapy for Helicobacter Pylori Eradication in Females As Compared with Males Drug: Bismuth Subcitrate 120 MG Oral Tablet, Esomeprazole 40mg, Metronidazole 250 MG - Helicobacter Pylori Infection, Sex | Phase 4 | Enrolling by invitation | National Cheng-Kung University Hospital | 661 | 2024-07-09 | 2024-11-07 |
| Efficacy and Safety of a Triple Eradication Scheme for Helicobacter Pylori Based on Tegoprazan vs Esomeprazole Tegoprazan, Esomeprazole 40mg - Helicobacter Pylori Infection | Phase 4 | Unknown | Hospital General de México Dr. Eduardo Liceaga | 160 | 2024-04-19 | 2024-03-19 |
| The ESG Integrity Study: Effect of Proton Pump Inhibitors on the Structural Integrity of Endoscopic Sleeve Gastroplasty Esomeprazole - Obesity | Phase 4 | Unknown | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 40 | 2024-02-01 | 2024-02-28 |
| Levofloxacin Concomitant Versus Levofloxacin Sequential sequential, Levofloxacin 500Mg Oral Tablet - Helicobacter Pylori Infection | Phase 4 | Not yet recruiting | Damascus Hospital | 150 | 2024-01-02 | 2023-10-03 |
| Study on the Efficacy and Safety of Berberine, Minocycline, Esomeprazole, and Colloidal Bismuth Quadruple Therapy in the Initial Treatment of Helicobacter Pylori. esomeprazole, Bismuth, Amoxicillin - Helicobacter Pylori Infection, Chronic Gastritis | Phase 4 | Unknown | Xijing Hospital of Digestive Diseases | 548 | 2023-11-20 | 2024-09-19 |
| Tegoprazan-Amoxicillin Dual Therapy vs. Bismuth Quadruple Therapy for H. Pylori Infection (TATH-1) Tegoprazan 50 mg, tablets, orally, qd, Esomeprazole 20mg BID, Tegoprazan 50 mg, tablets, orally, bid - Helicobacter Pylori Infection | Phase 4 | Completed | Zhang Xiaofeng,MD | 370 | 2023-11-01 | 2026-01-16 |
| Efficacy of Proton Pump Inhibitors in Cirrhotic Patients With Acute Variceal Bleeding Proton Pump Inhibitors, No Proton Pump Inhibitors - Upper Gastrointestinal Hemorrhage | Phase 4 | Not yet recruiting | West China Hospital | 672 | 2023-10-01 | 2023-09-28 |
| Doxycycline for Helicobacter Pylori Rescue Treatment Esomeprazole, Bismuth Potassium Citrate, Tetracycline - Helicobacter Pylori Infection | Phase 4 | Recruiting | Shanghai Jiao Tong University School of Medicine | 368 | 2023-06-20 | 2024-12-30 |
| Helicobacter Rescue Therapy With Vonorazon and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple Therapy Vonoprazan, amoxicillin, Bismuth - Gastritis Dyspepsia Helicobacter Pylori Infection Gastric Cancer Peptic Ulcer | Phase 4 | Completed | Yongquan Shi | 688 | 2023-06-06 | 2025-07-03 |
| PPI Infusion Versus Oral Acid Pump Inhibitors for Bleeding Peptic Ulcers Vonoprazan, esomeprazole - Upper GI Bleeding, Proton Pump Inhibitors | Phase 4 | Recruiting | Chinese University of Hong Kong | 594 | 2023-05-18 | 2026-03-18 |
| A Study to Evaluate the Efficacy and Safety of Tegoprazan in GERD Patients With Nighttime Heartburn Tegoprazan, Esomeprazole - Gastroesophageal Reflux Disease | Phase 4 | Unknown | HK inno.N Corporation | 338 | 2023-03-24 | 2023-08-03 |
Showing 20 of 152. Sign in to see all of them.
Gastroesophageal Reflux (33) · Heartburn (16) · Dyspepsia (12) · Gastritis (8) · Peptic Ulcer (8) · Stomach Neoplasms (5) · Gastrointestinal Hemorrhage (4) · Helicobacter Infections (4) · Peptic Ulcer Hemorrhage (4) · Stomach Ulcer (4) · Barrett Esophagus (3) · cyclopia sequence (3) · Abdominal Pain (2) · Acute Coronary Syndrome (2) · Colorectal Neoplasms (2)
AstraZeneca (35) · Shanghai Jiao Tong University School of Medicine (12) · Xijing Hospital of Digestive Diseases (8) · Damascus Hospital (5) · Shandong University (5) · National Taiwan University Hospital (4) · Chinese University of Hong Kong (3) · National Cheng-Kung University Hospital (3) · Ruttonjee Hospital (3) · Chang Gung Memorial Hospital (2) · EMS (2) · HK inno.N Corporation (2) · Second Affiliated Hospital, Zhejiang University, School of Medicine (2) · Seoul National University Bundang Hospital (2) · Yongquan Shi (2)
China (43) · United States (21) · Taiwan (14) · South Korea (6) · Denmark (5) · Syria (5) · Germany (4) · France (3) · Greece (3) · Netherlands (3) · Sweden (3) · Belgium (2) · Brazil (2) · Canada (2) · Hong Kong (2)
Paula Fernstrom (11) · Hong Lu, M.D. (3) · Marouf M Alhalabi, MD (3) · Yongquan Shi, Ph. D (3) · Bor-Shyang Sheu, MD (2) · Fook Hong Ng, MBBS (2) · Hong Lu, M.D (2) · Hong Lu, M.D.,Ph.D. (2) · Jyh-Ming Liou, MD, PhD (2) · Sang Kil Lee, Ph.D (2) · Xiuli Zuo, MD,PhD (2) · Andreas Franke, MD (1) · Ansgar W Lohse, MD (1)
PMID 32348007, PMID 15371921, PMID 15691312, PMID 25478944, PMID 25741163, PMID 27707777, PMID 28456631, PMID 29914954, PMID 34836916, PMID 12161727, PMID 12526935, PMID 16481828, PMID 16948806, PMID 17305763, PMID 18493207, PMID 19210493, PMID 19236727, PMID 19601705, PMID 20230209, PMID 20456300, PMID 20458079, PMID 20540767, PMID 20551454, PMID 20706150, PMID 21083590, PMID 21083673, PMID 21288053, PMID 21317257, PMID 21908799, PMID 22093203, PMID 22108447, PMID 22463723, PMID 22681960, PMID 22759841, PMID 22813439, PMID 23158886, PMID 23432146, PMID 24050512, PMID 24658598, PMID 24917966, PMID 25245625, PMID 25304129, PMID 25801708, PMID 26121347, PMID 26121348, PMID 26246908, PMID 26422095, PMID 26422096, PMID 27769562, PMID 28751088
2014 (1), 2019 (1), 2023 (1)